Revenue
$502.7M
▲ 27.8% YoY
Net Income
-$60.6M
▲ 6.3% YoY
EPS
$-0.54
▲ 23.9% YoY
Cash
$33.6M
▼ 32.4% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Kaushal Mohit | Sell | Apr 16, 2026 | 38.4K | $3.50 | $135K | Form 4 ↗ |
Kaushal Mohit | Sell | Apr 14, 2026 | 57.3K | $3.50 | $201K | Form 4 ↗ |
Chernett Jorey | Buy | Apr 9, 2026 | 20.0K | $3.10 | $62K | Form 4 ↗ |
Langsam Jeffrey Chief Clinical Officer | Grant | Mar 27, 2026 | 70.3K | $0.00 | $0 | Form 4 ↗ |
England Kristin Chief Administrative Officer | Grant | Mar 27, 2026 | 55.7K | $0.00 | $0 | Form 4 ↗ |
Podnos Yale Chief Medical Officer | Grant | Mar 27, 2026 | 66.4K | $0.00 | $0 | Form 4 ↗ |
Podnos Yale Chief Medical Officer | Sell | Mar 27, 2026 | 16.2K | $3.07 | $50K | Form 4 ↗ |
Carter Robert Ross Chief Financial Officer | Grant | Mar 27, 2026 | 202.9K | $0.00 | $0 | Form 4 ↗ |
Carter Robert Ross Chief Financial Officer | Sell | Mar 27, 2026 | 20.3K | $3.07 | $62K | Form 4 ↗ |
Virnich Daniel Chief Executive Officer | Grant | Mar 27, 2026 | 670.6K | $0.00 | $0 | Form 4 ↗ |
Virnich Daniel Chief Executive Officer | Sell | Mar 27, 2026 | 98.5K | $3.07 | $302K | Form 4 ↗ |
Chernett Jorey | Buy | Mar 27, 2026 | 27.4K | $2.96 | $81K | Form 4 ↗ |
Chernett Jorey | Buy | Mar 26, 2026 | 50.0K | $3.15 | $158K | Form 4 ↗ |
Chernett Jorey | Buy | Mar 24, 2026 | 125.0K | $3.11 | $389K | Form 4 ↗ |